Discussion
Implanon was introduced into the UK in 1999. Clinical trials have shown a 0% failure rate. We report a case of true method failure and the first known case of twin pregnancy conceived with Implanon in situ. A case report published in October 2005 described an ectopic pregnancy with Implanon in situ in France. 1 An article published in Australia raised the possibility of 13 reported pregnancies with Implanon with no identifiable cause. 2 Implanon contains 68 mg etonogestrel, which is sufficient to prevent ovulation. 3 The present case raises the possibility that two oocytes may in fact have been released. It is interesting to note that this woman had regular periods with Implanon in situ. In our experience this is unusual. Of this woman's six pregnancies, three were conceived whilst using hormonal contraception. Since compliance is not an issue here, this case raises the possibility that for some women with no apparent risk factors, hormonal contraceptives may never provide them with adequate contraceptive protection.
The case has had a profound effect on the patient both psychologically and emotionally. She feels unable to trust contraceptives and is nervous about the possibility of a future pregnancy. Her husband is considering vasectomy. Conversely, she has grieved the loss of her pregnancy and has contemplated another pregnancy but is afraid she would be unable to cope with a further miscarriage. This case underlines the importance of counselling prior to commencing any contraceptive method since none of the currently available methods are 100% effective.
